周明智Ming-Chih Chou林育民Yu-Min Lin醫學研究所2026-10-299999-12-312013https://handle.ncl.edu.tw/11296/uatn8bhttps://scholars.csmu.edu.tw/handle/123456789/35908趨化素2 (chemokine ligand 2;CCL2)別名為單核球趨化蛋白-1 (monocyte chemoattractant protein-1;MCP-1),又稱為small inducible cytokine A2,屬於趨化因子家族。CCL2與退化性骨關節炎及其預後有關。本研究探討在人類滑液纖維母細胞中,CCL2誘導血管細胞黏著分子-1 (vascular cell adhesion molecule-1;VCAM-1)的訊息傳遞之機轉。我們收集退化性關節炎病人和正常的滑液囊組織及THP-1細胞株來進行研究,並且利用及時聚合酶連鎖反應(quantitative real-time PCR)、西方墨點法分析 (western blot analysis)、流式細胞分析 (flow cytometry analysis)、siRNA轉染 (siRNAs transfection)、細胞黏附分析 (cell adhesion assay)、染色質免疫沉澱分析 (chromatin immunoprecipitation assay)等實驗來探討CCL2調控人類滑液纖維母細胞的訊息傳遞路徑。將退化性關節炎的滑液纖維母細胞以CCL2刺激後會促使VCAM-1表現。細胞以CCR2抑制劑 (RS102895)、PKC抑制劑 (rottlerin)、p38MAPK抑制劑 (SB203580)及AP-1抑制劑 (curcumin和tashinone IIA)作用後,抑制CCL2誘導退化性關節炎滑液纖維母細胞誘發VCAM-1的表現。細胞在CCL2作用下,促進PKC及p38MAPK訊息分子的活化及c-Jun磷酸化,也促使c-Jun結合到VCAM-1 啟動子上的AP-1 element。此外,CCL2會藉由CCR2、PKC、p38MAPK及AP-1訊息傳遞路徑促進單核球附著到退化性關節炎滑液纖維母細胞上。由我們實驗結果顯示CCL2經由CCR2、PKC、p38MAPK、c-Jun及AP-1信息傳遞路徑,進而影響人類骨關節炎滑膜纖維母細胞的VCAM-1的表現。Chemokine ligand 2 (CCL2), also referred to monocyte chemoattractant protein-1 (MCP-1) or small inducible cytokine A2, belongs to the CC chemokine family that is associated with the disease status and outcomes of osteoarthritis (OA). Therefore, we investigated the intracellular signaling pathways involved in CCL2-induced vascular cell adhesion molecule-1 (VCAM-1) expression in human OA synovial fibroblasts (OASFs). Human synovial fibroblasts, harvested from patients with osteoarthritis and with normal synovial tissues, and THP-1 cell line were cultured as specimens. Signal pathways were investigated with quantitative real-time PCR, western blot analysis, flow cytometry analysis, transfection of siRNAs, cell adhesion assay, and chromatin immnoprecipitation assay. Stimulation of OASFs with CCL2 induced VCAM-1 expression. CCL2-mediated VCAM-1 expression was attenuated by CCR2 inhibitor (RS102895), PKC inhibitor (rottlerin), p38MAPK inhibitor (SB203580), and AP-1 inhibitors (curcumin and tanshinone IIA). Stimulation of cells with CCL2 increased PKC and p38MAPK activation. Treatment of OASFs with CCL2 increased the c-Jun phosphorylation and c-Jun binding to the AP-1 element on the VCAM-1 promoter as well. Furthermore, the CCL2-mediated CCR2, PKC, p38MAPK, and AP-1 pathway promoted the adhesion of monocytes to the OASF monolayer. Our results suggest that CCL2 increases VCAM-1 expression in human OASFs via the CCR2, PKC, p38MAPK, c-Jun, and AP-1 signaling pathway. The CCL2-induced VCAM-1 expression promoted monocyte adhesion to human OASFs.趨化素-2與人類滑液纖維母細胞血管上皮細胞表面黏著分子-1之關係thesis